Induced Abortion in First Trimester Not Linked to Rh Sensitization
THURSDAY, Oct. 19, 2023 (HealthDay News) -- Induced first-trimester abortion is not associated with Rh sensitization, according to a study published online Sept. 26 in the Journal of the American Medical Association.
Sarah Horvath, M.D., from Penn State University College of Medicine in Hershey, and colleagues conducted a multicenter, observational, prospective cohort study to detect circulating fetal red blood cells (fRBCs) in paired maternal blood samples before and after induced first-trimester abortion. Paired blood samples were available for 506 participants who underwent medical or procedural abortion (63.0 and 37.0 percent, respectively).
The researchers found that three of the participants had elevated fRBC counts at baseline; one of these had an elevated fRBC count after abortion (0.2 percent). After induced first-trimester abortion, no other participants had elevated fRBC counts above the sensitization threshold. The median change from baseline in fRBC counts was 0, with upper 95th and 99th percentiles of 24.0 and 35.6 fRBCs, respectively. A strong association was seen between preabortion and postabortion fRBC counts, but no other baseline characteristic was associated with postabortion fRBC count.
"This evidence should inform the alignment of international guidelines and clinical care surrounding Rh immunoglobulin following first-trimester induced abortion," the authors write.
One author disclosed ties to Athenium Pharmaceuticals and has a patent for medical management of nonviable pregnancy.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Jynneos Vaccine Protects Against Monkeypox in Early U.S. Data
WEDNESDAY, Sept. 29, 2022 (HealthDay News) – The Jynneos vaccine, originally...
AHA News: When This Therapist Recommends Self-Care, It’s Not Self-Indulgence
THURSDAY, July 6, 2023 (American Heart Association News) -- As a psychotherapist...
Obamacare May Have Helped Extend Lives of Young Cancer Patients
TUESDAY, Dec. 27, 2022 (HealthDay News) -- Young adults with cancer, especially...
La FDA pide a los fabricantes de vacunas que actualicen los refuerzos para las variantes de la ómicron
JUEVES, 30 de junio de 2022 (HealthDay News) -- La Administración de Alimentos y...